|Year : 2018 | Volume
| Issue : 1 | Page : 109-112
Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus
Soumen Roy1, Lalit Samant1, Rajeshkumar Ganjhu2, Sandeepan Mukherjee1, Abhay Chowdhary1
1 Department of Virology, Haffkine Institute, Mumbai, India
2 Radhika Ayurvedic Research and Development, Pune, Maharashtra, India
|Date of Web Publication||19-Feb-2018|
Dr. Soumen Roy
Department of Virology, Haffkine Institute for Training, Research and Testing. A D Marg, Parel, Mumbai - 400 012, Maharashtra
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Objective: The soxhlet, cold, and ayurvedic extracts of Datura metel Linn. were evaluated for in vivo antirabies activity. Materials and Methods: Soxhlet and cold extraction method were used to extract Datura (fruit and seed) extracts, and ayurvedic extraction of Datura was prepared. In vivo toxicity assay was performed as per the OECD 420. LD50dose was calculated by Reed and Muench method. The in vivo antirabies activity was screened in Swiss albino mice with the virus challenge dose of 10 LD50 (intracerebrally) in both preexposure (PE) and postexposure treatment with oral administration of Datura extracts in Swiss albino mice and observed for 21 days. The virus load in the mice brain was evaluated by TCID50 titration method. Results: Datura (ayurvedic preparation) was found to be nontoxic up to 2000 mg/kg in Swiss albino mice, i.e., 60 mg/30 g of mice, when administered (0.5 ml) orally and observed till 21 days. Up to 20% survival rate on the test group (PE of Datura extracts) up to 14 days postinfection as compared to the virus control group (10 LD50) was observed. No survival rate was observed in the postexposure group of Datura extract; however, the survival time was increased by 4 days as compared to the virus control group. Viral load of the infected mice brain sample was estimated in vero cell line, and 3 log reduction in the virus titer was observed in text group as compared to the virus control, suggesting that Datura extract has an in vivo antirabies activity. Conclusion: To the best of our knowledge, this is the first study of in vivo antiviral activity of an ayurvedic preparation of D. metel Linn. against rabies virus. Datura extracts have a potential in vivo antirabies activity.
Keywords: Antirabies, Datura, in vivo antiviral assay, rabies
|How to cite this article:|
Roy S, Samant L, Ganjhu R, Mukherjee S, Chowdhary A. Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus. Phcog Res 2018;10:109-12
|How to cite this URL:|
Roy S, Samant L, Ganjhu R, Mukherjee S, Chowdhary A. Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus. Phcog Res [serial online] 2018 [cited 2021 May 18];10:109-12. Available from: http://www.phcogres.com/text.asp?2018/10/1/109/225810
Abbreviation Used: TCID50: tissue culture infectious dose 50; LD50: lethal dose 50; RV CVS: Rabies virus challenge virus standard; PE: Pre exposure; IC: intracerebral; PI: post infection; FITC: Fluorescein isothiocyanate
- In the present study, Datura metel Linn. (ayurvedic preparation) extract exhibited survival (20%) in the preexposure (PE) of the virus and the survival time was increased in the postexposure treatment where the disease was established. The mortality was observed, and the viral load was determined by titration method.
| Introduction|| |
Rabies is a fatal viral zoonotic disease which causes encephalitis in all warm-blooded animals, including humans, continued to be a serious problem in Africa. Rabies, a disease known to humanity for over 100 years, is till date considered a fatal killer once the symptoms begin to appear. The burden of the disease is quite high with nearly 55,000 people dying of this dreadful disease globally, of which approximately 29,000 deaths being reported annually from India alone.
Rabies caused by a single-stranded, negative-sense RNA virus is maintained in nature by a variety of animal reservoirs and primarily infects the central nervous system (CNS), resulting in progressive encephalopathy and ultimately death in an infected human.
Rabies prevention can be achieved by elimination of exposure and by vaccination through PE prophylaxis and postexposure treatment. PE rabies prophylaxis affords a measure of protection for unrecognized rabies exposures and simplifies postexposure treatment. Postexposure treatment is recommended following exposure to a potentially rabid animal and involves treatment of wound and administration of rabies vaccine as well as rabies immunoglobulin for individuals not previously vaccinated. Despite the availability of prevention and prophylaxis measures, rabies continues to be a threat globally.
Rabies is an acute viral infection of the CNS that is usually fatal in humans and animals. Rabies causes about 55,000 human deaths annually worldwide, with 95% of human deaths due to rabies occur in Asia and Africa. India has the highest rate of human rabies in the world, primarily because of stray dogs, whose number has greatly increased since a 2001 law forbade the killing of dogs. A total of 20,000 people are estimated to die every year from rabies in India more than one-third of the global toll.,
Plants serve as a source to treat different ailments. Many useful drugs have been developed from medicinal plants used in traditional medicine in the treatment of a variety of illnesses.
Datura has long been used as an extremely effective treatment for asthma symptoms. The active antiasthmatic agent is atropine, which causes paralysis of the pulmonary branches of the lungs, eliminating the spasms that cause the asthma attacks. The leaves are generally smoked either in a cigarette or a pipe. This practice of smoking Datura to relieve asthma has its origins in traditional ayurvedic medicine in India. Datura also has a wide range of traditional application including epilepsy, hysteria, insanity, heart, and skin diseases. It also cures mental diseases and relieves pain.
Therapeutic human rabies immunoglobulin and vaccine are available against rabies virus, but it is ineffective once the virus enters the CNS. There was only one reported case of a female survival from rabies virus by inducing coma and treating her with a combination of known antiviral drugs (Milwaukee protocol). Therefore, the search for more effective antiviral agents against viral infections of the CNS is a necessary and highly desirable task. This necessitates the need for the development of novel antivirals against rabies virus. Plant secondary metabolites have tremendous potential to be antiviral agents.
The potential of Datura plant extract was exhibited by in vitro model where Datura extract was found to have a pronounced in vitro antirabies activity.
However, the in vivo antiviral potential of Datura was not explored earlier. This study intended to evaluate the in vivo antirabies activity of Datura extract in a murine model.
| Materials and Methods|| |
Collection of plant material
Datura fruit was collected from the Phool market, Dadar, Mumbai. Plant specimen was authenticated and deposited in Blatter Herbarium, Department of Botany, St. Xavier's College, Mumbai, Maharashtra, India.
Preparation of plant extracts
The Datura seed separated from the fruit and was air dried and then was soaked in cow urine for 12 h. After 12 h, the seed was separated from the cow urine and air-dried. The dried seed was then boiled for 3 h in cow milk. After treatment with milk, the Datura seed was separated from the milk, and the seed cover was peeled out from the Datura seed. The peeled Datura seed was air-dried and then fine grinded and stored for further use. During processing, the seed powder was dissolved in water and was used for the antiviral assay.
Swiss albino mice aged from 4 to 6 weeks were purchased from Haffkine Institute (animal house), and the study was approved by the Institutional Animal Ethics Committee (IAEC) HITRT/IAEC/19/2013. The challenged virus standard strain of fixed rabies virus (RV CVS) was passaged in Swiss albino mice (30 μl intracerebrally) to increase the virus titer, and RV CVS stock suspension (10% w/v) was stored at −80°C. The LD50 dose was calculated by Reed and Muench method, and based on the 1 LD50 of the RV CVS, a challenge dose of 10 LD50 RV CVS was used in PE and postexposure treatments with Datura extracts.
In vivo toxicity of Datura extracts
The oral toxicity study was performed using fixed dose method (OECD guideline no. 420). The mice (3 weeks old) were provided from the Animal House Department, Haffkine Institute for the acute oral toxicity of the Datura extracts.
A single dose of Datura metel extracts was prepared as per 2000 mg/kg body weight of the Swiss albino mice for the fixed dose method. Swiss albino mice were grouped as per the sex and weight of the animal, and six mice per test group were considered for the toxicity study.
The concentration of 2000 mg/kg each extract was administered orally in the test group and observed for 21 days for mortality and morbidity. After 21 days, the animals were sacrificed and the toxicity was observed in major viral organs by for histopathological examination.
Titration of stock virus
The challenge virus (RV CVS) was stored as a 10% suspension in −80°C in the ampule/cryovials. Shortly before the test is carried out, a vial is taken from the stock and thawed rapidly under the tap. Serial tenfold dilution was then prepared (10− 1 up to10− 7) in the vials and the LD50 was calculated.
In the PE treatment, the test group of Swiss albino mice (10 mice/group) was administered orally (20 mg/ml) with the single dose of Datura extracts for 3 days, followed by the challenge dose of (30 μL intracerebrally) 10 LD RV CVS was inoculated onto the test (PE) Swiss albino mice. The virus control group of mice (10 mice/group) was inoculated intracerebrally with 10 LD50 RV CVS. Postinfection (PI) after 6 h, the test groups were orally administered (20 mg/ml) Datura extract for 14 days. All the group of mice was observed mortality up to 21 days.
In the postexposure treatment, the test group of Swiss albino mice (10 mice/group) was inoculated intracerebrally (30 μl) with the challenge dose of 10 LD50 RV CVS followed by the oral administration (after 6 h) of the Datura extracts (20 mg/ml) in the test group of mice. The virus control group (10 mice/group) of mice was inoculated intracerebrally with 10 LD50 RV CVS and the extract control group (10 mice/group) of mice was administered with the Datura extracts. The test group and the extract control group of mice (10 mice each) were administered up to 14 days and all the groups of mice were observed mortality up to 21 days.
Virus-releasing study by titration
The infected brain suspension was serially diluted in medium and infected in a 96 well plate with vero cell line and incubated for 72 h in a 37°C, CO2 incubator for virus titration. After incubation, the infected cells were fixed with chilled acetone and stained with FITC-tagged antibodies and were observed under a fluorescent inverted microscope. The viral load was calculated by TCID50 titration method and the virus titer was determined by fluorescent antibody test method.
Statistical analysis was performed using two-way analysis of variance test with GraphPad Prism 5.1 software Inc, (La Jolla California USA).
| Results and Discussion|| |
In vivo toxicity of crude extracts
Datura extract was not found to be toxic up to 2000 mg/kg body weight of Swiss albino mice, i.e., 60 mg/30 g of mice when administered (0.5 ml) orally and observed till 21 days. The LD50 titer was calculated by the Reed and Muench method. The titer of 104.75 LD50/0.03 ml RV CVS (1 LD50) was obtained. Based on the 1 LD50, the challenge dose of 10 LD50 RV CVS was used for the in vivo antirabies activity by PE and postexposure treatment.
In a PE treatment, we observed 20% survival rate on the test group (PE of Datura extracts) even after 21 days PI as compared to the virus control group of mice where mortality was observed on 10 day PI [Figure 1].
|Figure 1: Pre-exposure treatment of Datura (ayurvedic) extracts against a challenge dose of 10 LD50 challenged virus standard strain of fixed rabies virus. The results are expressed as standard error of the mean for each Group|
Click here to view
In a postexposure treatment, no survival rate was observed in the test group; however, survival time was increased by 4 days in the test group of mice as compared to the virus control group of mice where the mortality was observed in 10 days PI [Figure 2].
|Figure 2: Postexposure treatment of Datura (ayurvedic) extracts against a challenge dose of 10 LD50 challenged virus standard strain of fixed rabies virus. The results are expressed as standard error of the mean for each Group|
Click here to view
In vivo titration of the infected brain for rabies virus
In vivo, antirabies activity of Datura extracts was evaluated in Swiss albino mice when challenged with 10 LD50 RV CVS by PE and postexposure treatment. The infected test brains along with the virus control brains were harvested and titrated in vero cell line to determine the presence of the virus and the virus titer as compared with the virus control.
We observed 3 log and 1 log decreased in the virus titer of the test group of Datura PE treated and Datura postexposure treated infected brain suspension, respectively, as compared to the virus control brain suspension. The Datura (PE and postexposure) treatment significantly reduced the viral load in the Swiss albino mice when challenged with the 10 LD50 RV CVS as compared with the virus control [Figure 3].
|Figure 3: Titration of the test and virus control infected brain suspension. The results are expressed as standard error of the mean for each Group|
Click here to view
A single dose of Datura extracts (20 mg/ml) was administered orally followed by a challenge dose of 10 LD50 RV CVS (30 μl) inoculated intracerebrally in (3 weeks old) Swiss albino mice for both PE and postexposure trail experiment. In the PE treatment of Datura extract, we observed 20% survival rate on the test group up to 14 days PI as compared to the virus control group of mice where mortality was observed on 10 days PI. However, in the postexposure treatment, no survival rate was observed as the test group mice died as compared to the virus control group. However, survival time was increased by 4 days in the test group of mice as compared to the virus control group of mice where the mortality was observed in 10 days PI.
In the similar study, it was found that when the mice were administered with 1000 mg/kg dose of hydroethanolic extract Phytolacca dodecandra leaves, 33.3% survival rate was observed when challenged with rabies virus as compared to the virus control. However, 10% survival rate was found at the 600 mg/kg dose of the extract in mice and no survival was at 300 mg/kg dose of hydroethanolic extract P. dodecandra leaves when challenged with rabies virus as compared to the virus control.
Datura is a wild plant having various medicinal and pharmacological properties. Phytochemical of the plant are alkaloids, atropine, scopolamine, tannin, saponins, glycosides, phenol, sterols, lignins, fats, carbohydrates, and proteins.
Datura plant contains high levels of tropane alkaloids such as atropine, hyoscyamine, and scopolamine. Atropine and scopolamine are muscarinic antagonists which can be used to treat Parkinson's diseases and parasympathetic stimulation of the eye, heart, urinary, respiratory, and gastrointestinal tract. Anticholinergics are a class of compounds that inhibit parasympathetic nerve impulses by selectively blocking the binding of the neurotransmitter acetylcholine to its receptor in nerve cells. Atropine is an anticholinergic agent that blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system. Rabies virus also interacts with the acetylcholine receptor in the CNS.
In the study, we observed efficacy in the PE treatment with Datura extract but in the postexposure treatment where the infection is established in the CNS, only the survival time was increased but no protection was observed. The possible mechanism might be the masking the acetylcholine receptors and preventing the entry and thereby neutralizing the virus. Earlier studies suggest that D. metel extracts have a wide range of antibacterial and antifungal activity.
In vitro study of Datura extract exhibited antirabies activity. We observed that in in vivo study of Datura exhibited promising antirabies activity. The Datura extract prolonged the survival time by 4 days in the postexposure treatment whereas 20% survival rate was observed in the PE treatment in a murine model. Further research needs to be done on the mechanism of Datura to assess its protective role in rabies treatment.
| Conclusion|| |
Datura extract has an in vivo antirabies activity, as 20% survival rate was observed in the PE treatment. Moreover, also the survival time was increased in the PE treatment after the disease was established in a murine model. Further research needs to be done on the mechanism of Datura to assess its protective role in rabies treatment.
We would like to thank Haffkine Institute, Mumbai, for providing animals and NIMHANS, Bengaluru, for providing RV CVS for the research work.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Takayama N. Rabies: A preventable but incurable disease. J Infect Chemother 2008;14:8-14.
Johnson N, McKimmie CS, Mansfield KL, Wakeley PR, Brookes SM, Fazakerley JK, et al.
Lyssavirus infection activates interferon gene expression in the brain. J Gen Virol 2006;87:2663-7.
Megid J, Appolinario CM, Mazzini AM, Almeida MF. Evaluation of cytokines concentration and percentage of survival of rabies virus-infected mice submitted to anti-rabies Vero-cell propagated vaccine and P. acnes
. Vet Immunol Immunopathol 2006;114:192-6.
Jackson AC. Update on rabies. Res Rep Trop Med 2011;2:31-3.
Lafon M. Evasive strategies in rabies virus infection. Adv Virus Res 2011;79:33-53.
Pennachio M, Jefferson L, Havens K. Uses and Abuses of Plant Derived Smoke: Ethnobotany as Hallucinogen, Perfume, Incense, and Medicine. New York: Oxford University Press; 2010. p. 6-7.
Gilani AH, Rahman AU. Trends in ethnopharmocology. J Ethnopharmacol 2005;100:43-9.
Barceloux DG. Medical Toxicology of Natural Substances: Foods, Fungi, Medicinal Herbs, Plants, and Venomous Animals. Hoboken, New Jersey: John Wiley & Sons; 2008. p. 1877-8.
Willoughby RE Jr., Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, et al.
Survival after treatment of rabies with induction of coma. N Engl J Med 2005;352:2508-14.
Roy S, Mukherjee S, Pawar S, Chowdhary A. Evaluation of In vitro
antiviral activity of Datura metel
Linn. Against rabies virus. Pharmacognosy Res 2016;8:265-9.
Müller V, Chávez JH, Reginatto FH, Zucolotto SM, Niero R, Navarro D, et al.
Evaluation of antiviral activity of South American plant extracts against herpes simplex virus type 1 and rabies virus. Phytother Res 2007;21:970-4.
OECD. Test No 423: Acute Oral toxicity – Acute Toxic Class Method, OECD Guidelines for the Testing of Chemicals. Section 4. OECD Publishing, Paris; 2002.
Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-7.
Appolinário CM. Ribavirin has an in vitro
antiviral effect in rabies virus infected neuronal cells but fails to provide benefit in experimental rabies in mice. J Virol Antivir Res 2013;2:1-5.
Dmasu PA, Deressa A, Mengistu A, Gebrewold G, Feyera T. In vivo
antirabies activity evaluation of hydroethanolic extract of roots and leaves of Phytolacca dodecandra
. Glob Vet 2014;12:12-8.
Sayyed A, Shah M. Phytochemistry, pharmacological and traditional uses of Datura stramonium
L. Rev J Pharmacogn Phytochem 2014;2:123-5.
Baer GM, Shaddock JH, Quirion R, Dam TV, Lentz TL. Rabies susceptibility and acetylcholine receptor. Lancet 1990;335:664-5.
Kaushik P, Goyal P. In vitro
evaluation of Datura innoxia
(thorn-apple) for potential antibacterial activity. Indian J Microbiol 2008;48:353-7.
[Figure 1], [Figure 2], [Figure 3]